Publications by authors named "Gregory Finucane"

Claim this Profile
A
A long-term follow-up of safety and clinical efficacy of NTCELL® [Immunoprotected (Alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease.
Eoin Mulroy, Barry Snow, Arnold Bok, Mark Simpson, Andrew Smith, Gregory Finucane

Parkinsonism Relat Disord· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease.
Barry Snow, Eoin Mulroy, Arnold Bok, Mark Simpson, Andrew Smith, Gregory Finucane

Parkinsonism Relat Disord· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varenicline improves motor and cognitive symptoms in early Huntington's disease.
Ailsa L McGregor, Jo Dysart, Malcolm D Tingle, Bruce R Russell, Rob R Kydd, Gregory Finucane

Neuropsychiatr Dis Treat· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Appointment of a Huntington's Disease Nurse Specialist has Reduced Admission Rate and Improved Admission Quality.
David Bourke, Gregory Finucane, Jo Dysart, Richard Roxburgh

J Huntingtons Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal lobe resection for refractory temporal lobe epilepsy at Auckland Hospital.
Ravi Suppiah, Edward Mee, Elizabeth B Walker, Lynair Roberts, Gregory Finucane

N Z Med J· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis